California hospice providers are facing an unprecedented wave of Medicare audits, payment suspensions, and revocations of Medicare contracts. While federal regulators have justified these aggressive enforcement actions as necessary to combat fraud within the hospice industry, many legitimate providers are finding themselves trapped in an enforcement net that has become increasingly broad, disruptive, and unforgiving.
In recent years, regulators have focused heavily on California’s hospice market due to concerns over rapid provider growth, allegations of fraudulent enrollment activity, and questionable billing practices among a subset of operators. In response, the Centers for Medicare & Medicaid Services (CMS) and its contractors have escalated oversight through Unified Program Integrity Contractors (UPICs), medical necessity audits, site visits, and prepayment review initiatives. Some sources say approximately 447 companies have had their reimbursements suspended. Dr. Oz stated that 800 hospice companies are affected.
Unfortunately, the government’s approach has often failed to distinguish between bad actors and compliant providers attempting to care for vulnerable patients in an already difficult regulatory environment.
For many hospices, the consequences begin with a records request and quickly escalate into something far more damaging. Providers frequently report receiving broad audit requests covering large numbers of claims over extended periods of time, often accompanied by aggressive documentation demands and unrealistic response deadlines. In some cases, payment suspensions are imposed before any formal finding of wrongdoing has been established.
The financial impact can be devastating.
Unlike many healthcare businesses, hospices operate on tight cash flow margins while managing significant staffing and operational costs. When Medicare payments are suspended — sometimes for months — providers may struggle to meet payroll obligations, maintain clinical services, or continue caring for terminally ill patients. Even providers ultimately cleared of wrongdoing can suffer irreversible operational damage simply from being caught in the process.
One of the most troubling aspects of these enforcement efforts is the government’s heavy reliance on data analytics and utilization patterns rather than individualized clinical review at the outset. Hospice providers with longer average lengths of stay, higher census numbers, or diagnosis patterns that differ from statistical norms may find themselves flagged for investigation even when their patient populations are entirely legitimate. AI is relied on heavily without any verification of accuracy.
But hospice eligibility is not always predictable or easily reduced to formulas.
Patients with conditions such as dementia, congestive heart failure, chronic obstructive pulmonary disease, and neurological illnesses often decline slowly and inconsistently. Prognostic uncertainty is part of hospice medicine itself. Yet auditors reviewing records years later frequently apply hindsight analysis to challenge physician certifications that were reasonable when made.
For example, a patient with advanced Alzheimer’s disease may stabilize temporarily after admission to hospice care. Regulators may later argue the patient was not terminally ill because they survived beyond six months. However, hospice physicians understand that Medicare regulations never require patients to die within six months — only that the physician reasonably expected a terminal prognosis at the time of certification.
This distinction is often lost during audits.
Innocent providers also become vulnerable because hospice documentation standards continue to evolve through contractor interpretation rather than clear regulatory guidance. Auditors frequently criticize records for lacking sufficient detail regarding decline, functional status, nutritional changes, or disease progression, even when clinicians believed the documentation adequately supported eligibility.
The result is an atmosphere where providers feel they are being judged against unwritten standards that shift during the course of the investigation.
Compounding the problem is the use of payment suspensions based merely on “credible allegations of fraud,” a relatively low threshold that does not require proof of intentional misconduct. In practice, providers may experience severe financial penalties long before they have a meaningful opportunity to defend themselves.
Many hospice operators describe the process as punitive first and investigative second. Despite, all the suspensions, the government is not always right and you do have rights.
This is not to suggest fraud does not exist within hospice care. Regulators unquestionably have an obligation to protect Medicare funds and investigate providers engaging in abusive practices. However, enforcement efforts become problematic when broad investigative tactics destabilize compliant providers alongside those intentionally violating the law.
For legitimate hospices facing audits or payment suspensions, early action is critical.
Providers should immediately preserve all clinical and billing documentation, conduct internal reviews of eligibility records, and engage experienced healthcare counsel before responding to government requests. Importantly, providers should avoid assuming that auditors will “understand” clinical judgment absent detailed supporting documentation. Every certification, recertification, and care plan should clearly explain the patient’s decline and the physician’s basis for terminal prognosis.
Hospices should also proactively evaluate whether their documentation practices align with current contractor expectations, particularly regarding narrative support for eligibility determinations and ongoing decline.
Most importantly, providers must recognize that silence or delay can significantly worsen the situation. Early strategic responses often help narrow the scope of investigations, address documentation concerns before escalation, and position providers more effectively if appeals become necessary.
California hospice providers are operating in one of the most heavily scrutinized healthcare sectors in the country. While enforcement may continue to intensify, regulators must also recognize that overly aggressive audit tactics risk harming the very providers caring for Medicare’s most vulnerable patients.